Isolated Candida albicans oligopeptide transporter gene
AssigneeThe University of Tennessee Research Corporation
InventorsJeffrey M. Becker, Mark A. Lubkowitz
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe University of Tennessee Research Corporation
InventorsJeffrey M. Becker, Mark A. Lubkowitz
Estimating the term…
A Candida albicans oligopeptide transport gene, OPT1, was cloned from a C. albicans genomic library through heterologous expression in the Saccharomyces cerevisiae di-/tripeptide transport mutant PB1X-9B. When transformed with a plasmid harboring OPT1, S. cerevisiae PB1X-9B, which did not express tetra-/pentapeptide transport activity under the conditions used, was conferred with an oligopeptide transport phenotype as indicated by growth on the tetrapeptide Lysyl-Leucyl-Leucyl-Glycine, sensitivivity to toxic tetra- and pentapeptides, and an increase in the initial uptake rate of the radiolabeled tetrapeptide Lysyl-Leucyl-Glycyl-[3H]Leucine. The entire 3.8 kb fragment containing the oligopeptide transport activity was sequenced and an open reading frame of 2349 nucleotides containing a 58 nucleotide intron was identified. The deduced protein product of 783 amino acid residues contained twelve hydrophobic regions suggestive of a membrane transport protein. The oligopeptide transporter facilitates targeting of antifungal, especially anticandidal drugs.
An isolated oligopeptide membrane transporter which is not a member of the Peptide Transport (PTR) or ATP Binding Cassette (ABC) families.
Dependencies are inferred from the claim text.